This is the authors' abstract. We don't add key points for this paper.
THE red-cell sickling tendency of certain persons has long been a matter of great interest. Study of this problem by Pauling and his associates1 led to the suggestion of a genetic change in hemoglobin formation that resulted in synthesis of different globin fractions for normal and sickle-cell hemoglobin. Subsequent investigation by Ingram2 has shown the specific globin abnormality to be a single amino acid substitution, valine for glutamic acid, in each identical half hemoglobin molecule containing approximately 300 amino acids. Sickle-cell anemia thus became the first example of a molecular disease in which the product of gene mutation was characterized . . .
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pierce et al. (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: